An NCI-designated Comprehensive Cancer Center, affiliated with the University of Pittsburgh School of Medicine
Research
We are pleased to announce James Ohr, DO, as Director of the Northwest Pennsylvania Clinical Trials Program for UPMC Hillman Cancer Center, effective August 1, 2025. In this new role, Dr. Ohr will provide leadership for our OHA medical oncology…
Please join us in welcoming Steven B. Chinn, MD, MPH, FACS, to UPMC Hillman Cancer Center, effective July 21, 2025. Dr. Chinn is Associate Professor in the Department of Otolaryngology at the University of Pittsburgh and will clinically focus on…
A $1.5 million gift will advance sarcoma research at UPMC Hillman Cancer Center through the establishment of the Dr. John A. Shoener Family Endowed Research Fund for Sarcoma. Jacqueline “Jackie” Shoener, inspired by her father’s lifelong commitment to health care…
Please join us in welcoming Curtis McCloskey, PhD, to UPMC Hillman Cancer Center, effective June 2, 2025. Dr. McCloskey is Assistant Professor in the Department of Computational and Systems Biology at the University of Pittsburgh. Dr.McCloskey’s research aims to drive…
Breast cancer is the most commonly diagnosed cancer among women worldwide. Patients diagnosed with breast cancer face the important question of what treatments to choose. While treatment decisions have become more refined over time, they are not yet personalized. Patients…
We are pleased to announce Yana Najjar, MD, as the recipient of this year’s Sy Holzer Endowed Immunotherapy Research Award to advance innovative research in cancer immunotherapy. Dr. Najjar is a research physician at UPMC Hillman Cancer Center, where is…
Please join us in welcoming Shirley S. Ong, MD, to UPMC Hillman Cancer Center, effective March 17, 2025. Dr. Ong is Associate Professor in the Department of Neurology. Dr. Ong will be involved in clinical research, developing and running clinical…
In honor of April being Head and Neck Cancer Awareness Month, we wanted to catch up with Marci Nilsen, PhD, RN, CHPN, FAAN, who we featured a couple years ago and was recently named co-lead for our cancer center’s Biobehavioral…
We are pleased to announce Hong Wang, PhD, as interim director of the Biostatistics Facility and Raman Venkataramanan, PhD, FCP, FAAPS, as interim director of the Cancer Pharmacokinetics and Pharmacodynamics Facility. Dr. Wang has been a biostatistician in the Biostatistics…
We are pleased to announce Marci Lee Nilsen, PhD, RN, CHPN, FAAN, as the new co-lead of UPMC Hillman Cancer Center’s Biobehavioral Cancer Control (BCC) Program, effective March 1, 2025. Dr. Nilsen has been a member of the BCC since…
